Completed OBSERVATIONAL NCT01302080

Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES) (SPRITES)

SPRITES: SERTRALINE PEDIATRIC REGISTRY FOR THE EVALUATION OF SAFETY A NON-INTERVENTIONAL, LONGITUDINAL, COHORT STUDY TO EVALUATE THE EFFECTS OF LONG-TERM SERTRALINE TREATMENT IN CHILDREN AND ADOLESCENTS

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Conditions Obsessive Compulsive Disorder

Interventions psychotherapy sertraline

Updated 20 times since 2017 Last updated: Oct 12, 2021 Started: Apr 4, 2012 Primary completion: Sep 9, 2020 Completion: Sep 9, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01302080, this observational or N/A phase trial focuses on Obsessive Compulsive Disorder and remains completed. Sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris Inc., it has been updated 20 times since 2012, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

20 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Nov 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Nov 2021 [monthly]

Completed

▶ Show 15 earlier versions

Dec 2020 — Jan 2021 [monthly]

Completed

Status: Active Not Recruiting → Completed
Jan 2020 — Dec 2020 [monthly]

Active Not Recruiting
Jan 2019 — Jan 2020 [monthly]

Active Not Recruiting
Dec 2018 — Jan 2019 [monthly]

Active Not Recruiting
Nov 2018 — Dec 2018 [monthly]

Active Not Recruiting
Sep 2018 — Nov 2018 [monthly]

Active Not Recruiting
Aug 2018 — Sep 2018 [monthly]

Active Not Recruiting
Jun 2018 — Aug 2018 [monthly]

Active Not Recruiting
Apr 2018 — Jun 2018 [monthly]

Active Not Recruiting

Phase: NA → None
Jan 2018 — Apr 2018 [monthly]

Active Not Recruiting NA
Oct 2017 — Jan 2018 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Jun 2017 — Oct 2017 [monthly]

Recruiting NA
Mar 2017 — Jun 2017 [monthly]

Recruiting NA
Feb 2017 — Mar 2017 [monthly]

Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Data source: Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Augusta, United States , Baltimore, United States , Boston, United States , Cary, United States , Chagrin Falls, United States , Charlottesville, United States , Cincinnati, United States , Cleveland, United States , Dallas, United States , Dothan, United States and 30 more locations